Our Strategy

Identify New Leads
Developing novel cancer drug discovery platforms

Test Lead Efficacy
Validating anti-cancer efficacy of drug leads in pre-clinical models

Intellectual Property
Acquiring and maintaining intellectual property portfolio

Commercialization
Maximizing the commercialization potential of drug leads

Clinical Testing
Advancing Investigational New Drug trials

Collaborations
Promoting drug discovery with a team strategy

Service
Providing high-quality research service in pre-clinical models

Society
Creating high-tech jobs and improving healthcare

Technology Pipeline

MetCure’s technology pipeline is currently focused on prostate cancer drugs, including small-molecule compounds and natural compounds (nutraceuticals). All the MetCure’s technologies are currently in pre-clinical phase.